Wang Z - Search Results

1

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.

Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q. Ma B, et al. Among authors: wang z. Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022. Front Oncol. 2022. PMID: 36158690 Free PMC article.

2

Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.

Wang Z, Zhang Y, Liu Y, Wang L, Zhao L, Yang T, He C, Song Y, Gao Q. Wang Z, et al. Among authors: wang l. J Immunother. 2014 Jan;37(1):43-50. doi: 10.1097/CJI.0000000000000005. J Immunother. 2014. PMID: 24316555

3

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.

Wang Z, Liu Y, Zhang Y, Shang Y, Gao Q. Wang Z, et al. Oncotarget. 2016 Jan 26;7(4):4760-9. doi: 10.18632/oncotarget.6734. Oncotarget. 2016. PMID: 26716894 Free PMC article.

4

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.

Wang Z, Liu Y, Li R, Shang Y, Zhang Y, Zhao L, Li W, Yang Y, Zhang X, Yang T, Nie C, Han F, Liu Y, Luo S, Gao Q, Song Y. Wang Z, et al. J Hematol Oncol. 2016 Feb 3;9:6. doi: 10.1186/s13045-016-0237-6. J Hematol Oncol. 2016. PMID: 26842696 Free PMC article.

5

Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells.

Wang Z, Till B, Gao Q. Wang Z, et al. Oncoimmunology. 2017 Jun 16;6(7):e1331807. doi: 10.1080/2162402X.2017.1331807. eCollection 2017. Oncoimmunology. 2017. PMID: 28811975 Free PMC article. Review.

6

Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patients.

Zhang Y, Zhu Y, Zhao E, He X, Zhao L, Wang Z, Fu X, Qi Y, Ma B, Song Y, Gao Q. Zhang Y, et al. Among authors: wang z. Immunotherapy. 2017 Nov;9(14):1165-1174. doi: 10.2217/imt-2017-0061. Immunotherapy. 2017. PMID: 29067881

7

Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma.

Zhao L, Li W, Wang Z, Yang Y, Zhang Y, Shang Y, Ren X, Gao Q. Zhao L, et al. Among authors: wang z. Immunotherapy. 2018 Mar 1;10(6):501-510. doi: 10.2217/imt-2017-0140. Immunotherapy. 2018. PMID: 29562855

8

Combination of Cytokine-Induced Killer Cells and Programmed Cell Death-1 Blockade Works Synergistically to Enhance Therapeutic Efficacy in Metastatic Renal Cell Carcinoma and Non-Small Cell Lung Cancer.

Wang Z, Liu X, Till B, Sun M, Li X, Gao Q. Wang Z, et al. Front Immunol. 2018 Jul 5;9:1513. doi: 10.3389/fimmu.2018.01513. eCollection 2018. Front Immunol. 2018. PMID: 30026742 Free PMC article.

9

Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency.

Yuan S, Hu X, Zhao Y, Wang Z. Yuan S, et al. Among authors: wang z. Front Immunol. 2020 Nov 6;11:563622. doi: 10.3389/fimmu.2020.563622. eCollection 2020. Front Immunol. 2020. PMID: 33240259 Free PMC article.

10

Advanced Renal-Cell Carcinoma Pseudoprogression After Combined Immunotherapy: Case Report and Literature Review.

Zhang X, Huang H, Han L, Li T, Wang Z, Gao Q. Zhang X, et al. Among authors: wang z. Front Oncol. 2021 May 28;11:640447. doi: 10.3389/fonc.2021.640447. eCollection 2021. Front Oncol. 2021. PMID: 34123792 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136,453 results

Search Page

Filters